Fact checked byKristen Dowd

Read more

December 01, 2022
2 min read
Save

Top news of November: Asthma and sex, two-drug inhalers, early peanut introduction, more

Fact checked byKristen Dowd
You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Healio compiled the most-read news in allergy, asthma and immunology posted in November.

Driven by our coverage of the American College of Allergy, Asthma & Immunology Annual Scientific Meeting in Louisville, Kentucky, highlights included sex as an asthma trigger, FDA panel support of a two-drug inhaler, the effectiveness of early peanut introduction in preventing allergy, use of a maternal diet index to predict allergic disease, and more.

Couple in bed
Much like exercise-induced asthma, sexual intercourse also can trigger asthma exacerbations. Source: Adobe Stock

Sexual intercourse may trigger asthma exacerbations

Ariel Leung

Allergists should ask their patients about all asthma triggers, including sexual intercourse, to better control the asthma and improve their patients’ quality of life, Ariel Leung, MD, of the Saint Agnes Medical Center, said during the ACAAI Annual Scientific Meeting. Read more.

FDA panel supports approval of two-drug asthma inhaler for adults, split on adolescents

The FDA’s Pulmonary-Allergy Drug Advisory Committee voted in favor of approval of the fixed-dose combination of budesonide and albuterol metered dose inhaler for adults with asthma but not for adolescents or children. Read more.

Early peanut introduction effective in preventing allergy

Introducing infants across the entire population to peanuts instead of just focusing on high-risk groups would reduce the allergy burden by 88%, Gideon Lack, MD, of King’s College London, said during the ACAAI Annual Scientific Meeting. Read more.

Maternal diet index indicates risk for allergic disease among offspring

Increases in maternal diet index scores were significantly associated with lower odds for allergic rhinitis, atopic dermatitis, asthma, wheeze and any allergy excluding wheeze, Carina Venter, PhD, RD, of Children’s Hospital Colorado, and colleagues wrote in The Journal of Allergy and Clinical Immunology: In Practice. Read more.

Speaker: Every patient encounter is an opportunity to address food allergy misconceptions

David Stukus

Misconceptions and misinformation abound surrounding food allergy, but clinicians can use the trust they have built with their patients to anticipate their concerns and address their questions, David Stukus, MD, FACAAI, of Nationwide Children’s Hospital, told his audience at the ACAAI Annual Scientific Meeting. Read more.

Solo, small practices can expand successfully with careful planning

As treatment options expand, doctors should be selective in what they offer while staffing and coding for these new options appropriately, Priya Bansal, MD, FAAAAI, of the Asthma and Wellness Center in Saint Charles, Illinois, said during her ACAAI Annual Scientific Meeting presentation. Read more.

Overlaps in shrimp, house dust mite allergies drive respiratory, other symptoms

Approximately half of a group of patients with IgE sensitization to shrimp also were sensitized to house dust mites, and vice versa, researchers from the Swedish University of Agricultural Sciences and Uppsala University wrote in Clinical and Translational Allergy. Read more.

Peanut patch reduces reaction severity in toddlers

The use of a peanut immunotherapy patch for 12 months appeared to reduce reaction severity while increasing eliciting dose among toddlers, Terri F. Brown-Whitehorn, MD, of Children’s Hospital of Philadelphia, said during her presentation at the ACAAI Annual Scientific Meeting. Read more.

Location of anaphylaxis episode influences epinephrine use in children

Children who experienced food-induced anaphylaxis at school received epinephrine administered via an autoinjector before going to the hospital more often than those experiencing anaphylaxis at home or at restaurants, researchers from Montreal Children’s Hospital reported in The Journal of Allergy and Clinical Immunology. Read more.

Immunotherapy skin patch shows efficacy for toddlers with peanut allergy

Matthew Greenhawt

Epicutaneous immunotherapy conferred a significant response after 12 months among children aged 1 to 3 years with peanut allergy, Matthew Greenhawt, MD, MBA, MSc, told the audience during his presentation at the ACAAI Annual Scientific Meeting. Read more.